APA (7th ed.) Citation

Fleifil, Y., Gulati, R., Jennings, K., Miethke, A., Bondoc, A., Tiao, G., . . . Timchenko, N. (2026). Fusion DNAJB1: :PRKACA in Non-Fibrolamellar Cancer Cases. Reply to Arif et al. Global Re-Analysis Confirms Absence of the DNAJB1::PRKACA Fusion in Hepatoblastoma. Comment on "Fleifil et al. DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways. Cancers 2025, 17 , 83". Cancers, 18(6), 918. https://doi.org/10.3390/cancers18060918

Chicago Style (17th ed.) Citation

Fleifil, Yasmeen, Ruhi Gulati, Katherine Jennings, Alexander Miethke, Alexander Bondoc, Gregory Tiao, Rebekah Karns, Lubov Timchenko, and Nikolai Timchenko. "Fusion DNAJB1: :PRKACA in Non-Fibrolamellar Cancer Cases. Reply to Arif Et Al. Global Re-Analysis Confirms Absence of the DNAJB1::PRKACA Fusion in Hepatoblastoma. Comment on "Fleifil Et Al. DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways. Cancers 2025, 17 , 83"." Cancers 18, no. 6 (2026): 918. https://doi.org/10.3390/cancers18060918.

MLA (9th ed.) Citation

Fleifil, Yasmeen, et al. "Fusion DNAJB1: :PRKACA in Non-Fibrolamellar Cancer Cases. Reply to Arif Et Al. Global Re-Analysis Confirms Absence of the DNAJB1::PRKACA Fusion in Hepatoblastoma. Comment on "Fleifil Et Al. DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways. Cancers 2025, 17 , 83"." Cancers, vol. 18, no. 6, 2026, p. 918, https://doi.org/10.3390/cancers18060918.